Theravance (THRX) Reports Q1 Loss of $0.09
Tweet
Share
E-mailGet Alerts THRX Hot Sheet
Join SI Premium – FREE
Theravance (NASDAQ: THRX) reported Q1 EPS of ($0.09), versus ($0.14) reported last year. Revenue for the quarter came in at $6.8 million, versus $7 million reported last year.
For earnings history and earnings-related data on Theravance (THRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Jefferies sees a buying opportunity in this S&P 500 sector
- SuperCom (SPCB) Tops Q3 EPS by 43c
- Wolfe Research upgrades Biogen, AbbVie on pipeline strength and valuation
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
